MLN8237 10 mg | ≥98% LKT Laboratories, Inc. AurKA inhibitor. More Information Supplier Page × MLN8237
PF-04691502 Dihydrate 10 mg | ≥98% LKT Laboratories, Inc. PI3K and mTOR inhibitor. More Information Supplier Page × PF-04691502 Dihydrate
PF-04691502 Dihydrate 5 mg | ≥98% LKT Laboratories, Inc. PI3K and mTOR inhibitor. More Information Supplier Page × PF-04691502 Dihydrate
PF-04691502 Dihydrate 1 mg | ≥98% LKT Laboratories, Inc. PI3K and mTOR inhibitor. More Information Supplier Page × PF-04691502 Dihydrate
Moclobemide 100 mg | ≥98% LKT Laboratories, Inc. MAO-A inhibitor. More Information Supplier Page × Moclobemide
Moclobemide 25 mg | ≥98% LKT Laboratories, Inc. MAO-A inhibitor. More Information Supplier Page × Moclobemide
Moclobemide 10 mg | ≥98% LKT Laboratories, Inc. MAO-A inhibitor. More Information Supplier Page × Moclobemide
Cambinol 25 mg | ≥98% LKT Laboratories, Inc. SIRT inhibitor. More Information Supplier Page × Cambinol
